M 344 Pill - orange round, 6mm
Pill with imprint M 344 is Orange, Round and has been identified as Ondansetron Hydrochloride 8 mg. It is supplied by Mylan Pharmaceuticals Inc.
Ondansetron is used in the treatment of Nausea/Vomiting; Nausea/Vomiting, Postoperative; Nausea/Vomiting, Chemotherapy Induced; Nausea/Vomiting, Radiation Induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 344




Ondansetron Hydrochloride
- Imprint
- M 344
- Strength
- 8 mg
- Color
- Orange
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- 5HT3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
corn starch,
sodium lauryl sulfate,
titanium dioxide,
triacetin,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-0344 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0525 (Discontinued) | UDL Laboratories Inc. |
Related images for "M 344"
More about ondansetron
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (476)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Patient resources
- Ondansetron drug information
- Ondansetron injection
- Ondansetron (Injection) (Advanced Reading)
- Ondansetron (Oral, Oromucosal) (Advanced Reading)
- Ondansetron Oral Soluble Film
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.